4 d

Alternatively, search?

com's Pill Identifier, a white, elliptical tablet imprinted with '44?

Pill imprint 44-527 has been identified as Acetaminophen 325mg, Guaifenesin 200 mg and Phenylephrine 5 mg. Alternatively, search by drug name or NDC code using the fields above. The following drug pill images match your search criteria 44-527 Color White Shape Capsule/Oblong View details Acetaminophen Strength 500 mg Imprint 44 175 Color White Shape Oval View details Acetaminophen Strength 500 mg Imprint M2A4 57344 Color White Shape Round View. Pill with imprint 44 338 is White, Oval and has been identified as Magnesium Salicylate magnesium salicylate 467 It is supplied by LK Magnesium salicylate is used in the treatment of Inflammatory Conditions; Pain and belongs to the drug class salicylates. However, the round shaped pill with the imprint an 627 is the exact one my pharmacy always carried, therefore filled my prescription with. goodman air conditioner age serial Pill with imprint 44 525 is White, Round and has been identified as Acta-Tabs PE chlorpheniramine 4 mg / phenylephrine 10 mg. Enter the imprint code that appears on the pill. 44-527 Color White Shape Capsule/Oblong View details J 44 Fexofenadine Hydrochloride Strength 180 mg Imprint J 44 Color Pink Shape Capsule/Oblong A 44 175 white pill is an over-the-counter (OTC) pain reliever and fever reducer that contains 500 milligrams of acetaminophen. ## The white oblong pill marked 44-542 is identified as. 3125 furr ct charlotte nc Penicillin v potassium is used in the treatment of Bacterial Infection; Fusospirochetosis, Trench Mouth; Clostridioides difficile Infection; Cutaneous Bacillus anthracis; Lyme Disease, Erythema … Enter the imprint code that appears on the pill. Tramadol is used in the treatment of Back Pain; Chronic Pain; Pain and belongs to the drug class Opioids (narcotic analgesics). Search by imprint, shape, color or drug name 44-527. Search by imprint, shape, color or drug name. ikea wall mount desk Search by imprint, shape, color or drug name. ….

Post Opinion